|EVOTF -- USA Stock|| |
USD 19.65 2.17 12.41%
Chairman of the Supervisory Board
Prof. Dr. Wolfgang Plischke was Chairman of the Supervisory Board at Evotec AG since June 17, 2014. He is Chairman of the Remuneration and Nomination Committee at the Company. From March 2006 until April 2014 he was Member of the Board of Management of Bayer AG. He was responsible for Technology, Innovation and Sustainability and for the AsiaPacific region. From January 2002 to February 2006, he was Head of the Pharmaceuticals Business Group at Bayer AG with responsibility for the global business with prescription drugs. From 2000 to 2002, he served as Head of the Pharmaceuticals Business Group in North America at Bayer AG. From 1995 to 2000, Prof. Dr. Plischke served as President of Bayer Yakuhin Ltd., Japan, with responsibility for Pharmaceuticals and Consumer Care. He began his career in 1980 with Bayers subsidiary Miles Diagnostics after completing his biology studies at Hohenheim University. Prof. Dr. Plischke was Member of the Supervisory Board of Bayer AG since April 2016. He also holds a number of offices outside of Bayer AG. He is Member of the Board of the Walter Siegenthaler Society and the Robert Koch Foundation. He is also a Member of the senate of the Helmholtz association. In July 2011, Prof. Dr. Wolfgang Plischke was appointed honorary professor for Business Chemistry at the Ludwig Maximilian University of Munich.
Age: 65 Chairman Since 2014 Ph.D
49 40 5 60 81 0 http://www.evotec.com
Wolfgang Plischke was Chairman of the Supervisory Board at Evotec AG since June 17, 2014. He is former member of the management board at Bayer AG.